ARTICLES BY THIS AUTHOR
- 2/5/2025
FDA approves new indication for Novo Nordisk’s Ozempic
Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 diabetes and chronic kidney disease. - 2/5/2025
McKesson to acquire controlling interest in Prism Vision
McKesson will purchase an 80% interest for approximately $850 million, while Prism Vision physicians will retain a 20% interest. - 2/5/2025
Speakers at DSN’s Issues Summit address opportunities in health, beauty
At the 26th annual event in New York City, leaders put a heavy emphasis on meeting patients’ and consumers’ needs. - 2/5/2025
Camber launches sirolimus oral solution
Sirolimus oral solution is an mTOR inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in certain patients. - 2/4/2025
Walmart buys shopping mall in Pennsylvania
Walmart has bought Monroeville Mall for $34 million. - 2/4/2025
PQA elects 2025 board of directors, executive committee
Four new members from diverse healthcare professions, organizations and industries have joined PQA’s board. - 2/4/2025
Private label sales rose 3.9% in 2024 to record $271B
Over the past four years, annual store brand dollar sales have increased by more than $51 billion, a 23.6% gain. - 2/4/2025
Walgreens looks back at Deans Advisory Council's progress on its anniversary
The Council’s first year has brought tangible solutions to strengthen the pharmacy talent pipeline. - 2/4/2025
Lupin receives FDA nod for generic Atrovent
Ipratropium bromide nasal solution 0.06% is indicated for symptomatic relief of rhinorrhea associated with the common cold or seasonal allergic rhinitis for adults and children aged five years and older. - 2/4/2025
CVS Pharmacy, Duquesne University intro program to address pharmacist shortage
The collaboration is intended to remove financial barriers to higher education and support the talent pipeline for future pharmacists.